Top Banner
Antiarrhythmic Drugs Antiarrhythmic Drugs Normal heart rate Normal heart rate Action potential Action potential ECG ECG
56

Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Dec 23, 2015

Download

Documents

Berenice Norris
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Antiarrhythmic DrugsAntiarrhythmic Drugs

• Normal heart rate Normal heart rate • Action potentialAction potential• ECGECG

Page 2: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.
Page 3: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Factors precipitate Factors precipitate arrhythmiasarrhythmias

• May includes :May includes :• Ischemia, hypoxia, electrolytes Ischemia, hypoxia, electrolytes

disturbance, excessive disturbance, excessive catecholamines exposure , catecholamines exposure , drug toxicity.drug toxicity.

Page 4: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Mechanisms of Mechanisms of arrhythmiasarrhythmias

1- 1- Disturbances in impulse formation.Disturbances in impulse formation.

• Vagal stimulation or Vagal stimulation or ββ- receptor blocking - receptor blocking drugs slow normal pacemaker .drugs slow normal pacemaker .

• Acceleration of pacemaker by Acceleration of pacemaker by hypokalemia or hypokalemia or ββ-- adrenoceptor adrenoceptor stimulants.stimulants.

• Development of ectopic pacemakersDevelopment of ectopic pacemakers.. - -• --

Page 5: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

2- Disturbances in 2- Disturbances in impulse conductionimpulse conduction

• May result from block ( nodal block or May result from block ( nodal block or bundle branch block .bundle branch block .

• Reentry : Reentry : • circus movementcircus movement In which one impulse reenters and In which one impulse reenters and

excites areas of the heart more excites areas of the heart more than than ones.ones.

• Some forms of reentry are Some forms of reentry are anatomical in shape as in Wolff-anatomical in shape as in Wolff-Parkinson Parkinson ––White syndrome. White syndrome.

Page 6: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.
Page 7: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Antiarrhythmic DrugsAntiarrhythmic Drugs

• Class 1Class 1 : Na+ channel blockers : Na+ channel blockers• Local anaesthetic effectLocal anaesthetic effect• -ve inotropic action-ve inotropic action• Class 1( A Class 1( A ): prolongs duration of action ): prolongs duration of action

potential & refractory period.potential & refractory period.• Have K+ channel blocking effectHave K+ channel blocking effect• Antimuscarinic & hypotensive effects.Antimuscarinic & hypotensive effects.

Page 8: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

. . Class1(B)Class1(B):Shorten the duration of :Shorten the duration of action potential & refractory period action potential & refractory period

– Class1(C)Class1(C) : No effect on the duration : No effect on the duration of action or refractory period.of action or refractory period.

• Class 11Class 11 : : ββ-adrenoceptor blockers.-adrenoceptor blockers.• Class 11Class 111: K+ channel blockers,1: K+ channel blockers,• Prolong duration of action potential Prolong duration of action potential

and refractory period.and refractory period.

Page 9: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

• Class1VClass1V : Ca++ channel blockers. : Ca++ channel blockers.• Miscellaneous drugs.Miscellaneous drugs.

Page 10: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Class 1(A) Class 1(A) Quinidine:Quinidine:

• Cinchona plantCinchona plant• Block open & inactivated sodium Block open & inactivated sodium

channelchannel• Block potassium channelBlock potassium channel• -ve inotropic effect-ve inotropic effect• Antimuscarinic effect Antimuscarinic effect duration of action potential & refractory duration of action potential & refractory

periods of atrium & ventricles.periods of atrium & ventricles.• HypotensiveHypotensive

Page 11: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.
Page 12: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

ECG changesECG changes

• Prolong Q-T intervalProlong Q-T interval• Widening QRS complexWidening QRS complex

Page 13: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

PhrmacokineticsPhrmacokinetics

• Well absorbed orallyWell absorbed orally• Highly bound to plasma proteinsHighly bound to plasma proteins• Metabolized in liver ( active metabolite)Metabolized in liver ( active metabolite)• 20% excreted unchanged in urine20% excreted unchanged in urine• Usually given as slow release Usually given as slow release

formulationformulation• I.M. painful, I.V(marked hypotension) I.M. painful, I.V(marked hypotension)

Page 14: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Clinical usesClinical uses

• Atrial flutter & fibrillation it returns Atrial flutter & fibrillation it returns the rhythm back to normal sinus the rhythm back to normal sinus rhythm.rhythm.

• Used in treatment of ventricular Used in treatment of ventricular arrhythmia.arrhythmia.

Page 15: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Adverse effects Adverse effects

• 1- Cardiac effects 1- Cardiac effects • A) Due to antimuscarinic effect ,in A.F.or A) Due to antimuscarinic effect ,in A.F.or

A.F. may precipitate ventricular A.F. may precipitate ventricular tachycardiatachycardia

• B) SyncopeB) Syncope• C)Torsade de pointesC)Torsade de pointes• D) Cardiac stand still (asystole) in D) Cardiac stand still (asystole) in

patients with sick sinus syndrome .patients with sick sinus syndrome .

Page 16: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.
Page 17: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Extracardiac adverse Extracardiac adverse effectseffects

• HypotensionHypotension

• Cinchonism (headache, Cinchonism (headache, dizziness,tinnitus,deafness )dizziness,tinnitus,deafness )

• Hypersensitivity reactions Hypersensitivity reactions (hepatitis,thrombocytopenia)(hepatitis,thrombocytopenia)

• GIT, GIT, diarrheadiarrhea,nausea,vomiting,nausea,vomiting

Page 18: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Drug interactionsDrug interactions

• Quinidine increases the plasma Quinidine increases the plasma level of digoxin by :level of digoxin by :

a) displacement from tissue a) displacement from tissue binding sitesbinding sites

b) decreasing digoxin renal b) decreasing digoxin renal clearanceclearance

Page 19: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

ProcainamideProcainamide

• As quinidine but :As quinidine but :• Less hypotensive Less hypotensive • Less antimuscarinic Less antimuscarinic • Less cardiotoxic Less cardiotoxic • Can be given safely by I.M. or I.V. Can be given safely by I.M. or I.V. • Metabolized in liver and give active Metabolized in liver and give active

metabolite which has a class 111 metabolite which has a class 111 activity .activity .

Page 20: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

ContinueContinue

• Eliminated through kidney .Eliminated through kidney .• More effective in ventricular arrhythmias More effective in ventricular arrhythmias

, it is the , it is the second drug of choice after second drug of choice after lidocaine in treament of ventricular lidocaine in treament of ventricular arrhythmia follow acute M.I.arrhythmia follow acute M.I.

• Effective in A.F. or A.F. due to Wolff Effective in A.F. or A.F. due to Wolff Parkinson White syndromeParkinson White syndrome

Page 21: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Adverse effectsAdverse effects

• Systemic lupus erythematosus like Systemic lupus erythematosus like syndrome.syndrome.

• GIT : Nausea , diarrheaGIT : Nausea , diarrhea• Torsade de pointesTorsade de pointes• HypotensionHypotension

Page 22: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Class 1(B)Class 1(B)

• LidocaineLidocaine• Shorten the duration of A.P.& R.P.Shorten the duration of A.P.& R.P.• Effective in ventricular Effective in ventricular

arrhythmias.arrhythmias.

Page 23: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.
Page 24: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

PharmacokineticsPharmacokinetics

• Well absorbed after oral Well absorbed after oral administration . Only 3% reach administration . Only 3% reach general circulation.general circulation.

• Given only by I.V. routeGiven only by I.V. route• Excreted via kidney .Excreted via kidney .• Half-life 2hrs.Half-life 2hrs.

Page 25: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Therapeutic usesTherapeutic uses

• First drug of choice in treatment of First drug of choice in treatment of ventricular arrhythmias due toventricular arrhythmias due to

• Acute myocardial infarctionAcute myocardial infarction• Digitalis toxicityDigitalis toxicity• AnaesthesiaAnaesthesia• Open heart surgeryOpen heart surgery

Page 26: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Adverse effectsAdverse effects

• Neurological effects :Neurological effects :(contraindicated in epileptic patients ).(contraindicated in epileptic patients ).

• Arrhythmias uncommon Arrhythmias uncommon

• Hypotension Hypotension

Page 27: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

MexiletineMexiletine

• Effective orallyEffective orally• Half-life (8-20hrs ).Half-life (8-20hrs ).• Used in chronic treatment of Used in chronic treatment of

ventricular arrhythmias.ventricular arrhythmias.• Effective in relieving chronic pain Effective in relieving chronic pain

due to diabetic neuropathy& nerve due to diabetic neuropathy& nerve injury.injury.

Page 28: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Adverse effectsAdverse effects

• Neurologic side effectsNeurologic side effects

Page 29: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Class1(c)Class1(c)

• FlecainideFlecainideNo effect on the duration of A.P.& No effect on the duration of A.P.&

R.P.R.P.

• Proarrhythmic Proarrhythmic

• Approved for refractory ventricular Approved for refractory ventricular arrhythmias.arrhythmias.

Page 30: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.
Page 31: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

PropafenonePropafenone

• Has a weak Has a weak ββ-blocking effect.-blocking effect.• Used to maintain sinus rhythm in Used to maintain sinus rhythm in

patients with supraventricular patients with supraventricular arrhythmias including AF.arrhythmias including AF.

• Adverse effectsAdverse effects : :Metallic taste, constipation .Metallic taste, constipation .

Page 32: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.
Page 33: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Class 11Class 11

Beta-Adrenoceptor-Blocking Drugs.Beta-Adrenoceptor-Blocking Drugs.Effective in atrial & ventricular Effective in atrial & ventricular

arrhythmias that associated with arrhythmias that associated with Increase in sympathetic activity .Increase in sympathetic activity .Reduce the incidence of sudden Reduce the incidence of sudden

arrhythmic death after myocardial arrhythmic death after myocardial infarction.infarction.

Page 34: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

ContinueContinue

• PropranololPropranolol

• Metoprolol ( Metoprolol ( ββ11 selective) selective)

• EsmololEsmolol

Very short acting used for Very short acting used for intraoperative & acute arrhythmiasintraoperative & acute arrhythmias

Page 35: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Class 111Class 111

• Potassium channel blockersPotassium channel blockers• ( Drugs that Prolong duration of ( Drugs that Prolong duration of

action potential & refractory period action potential & refractory period ).).

Page 36: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.
Page 37: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

SotalolSotalol

• Nonselective Nonselective ββ- adrenergic receptor - adrenergic receptor antagonist .antagonist .

• Is used for the treatment of :Is used for the treatment of : Life- threatening ventricular Life- threatening ventricular

arrhythmias.arrhythmias. To maintain sinus rhythm in To maintain sinus rhythm in

patients with atrial fibrillation.patients with atrial fibrillation. For treatment of supra & For treatment of supra &

ventricular arrhythmias in ventricular arrhythmias in pediatric pediatric age group. age group.

Page 38: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Ibutilide Ibutilide

• Given by a rapid I.V. infusion Given by a rapid I.V. infusion • excreted mainly as metabolites by excreted mainly as metabolites by

kidney.kidney.• Used for the acute conversion of Used for the acute conversion of

atrial flutter or atrial fibrillation to atrial flutter or atrial fibrillation to normal sinus rhythm.normal sinus rhythm.

• Q-T interval prolongation , so it Q-T interval prolongation , so it precipitates torsade de pointes.precipitates torsade de pointes.

Page 39: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

AmiodaroneAmiodarone

• A)A) cardiac effectscardiac effects

Sodium channel blocking Sodium channel blocking

Potassium channel blockingPotassium channel blocking

Calcium channel blocking Calcium channel blocking

β- adrenoceptor blocking β- adrenoceptor blocking

Page 40: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

ContinueContinue

• B) Extracardiac effect B) Extracardiac effect

Peripheral vasodilationPeripheral vasodilation

Page 41: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

PharmacokineticsPharmacokinetics

• Given orally Given orally • Slow onset of actionSlow onset of action• Long half-life(13-103 hrs ).Long half-life(13-103 hrs ).• Cumulative drug Cumulative drug • Is highly lipophilic , is concentrated Is highly lipophilic , is concentrated

in many tissues.in many tissues.• Eliminated by liver mostly as active Eliminated by liver mostly as active

metabolites.metabolites.

Page 42: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Clinical usesClinical uses

• Recurrent & refractory ventricular Recurrent & refractory ventricular & supraventricular arrhythmias .& supraventricular arrhythmias .

• Arrhythmias associated with Wolff Arrhythmias associated with Wolff Parkinson syndrome.Parkinson syndrome.

• In maintaining sinus rhythm in In maintaining sinus rhythm in patients with AF.patients with AF.

Page 43: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Adverse effectsAdverse effects

• Gray- blue skin discoloration & Gray- blue skin discoloration & photodermatitis .photodermatitis .

• Corneal microdeposits Corneal microdeposits corneal corneal opacity ,optic neuritis, blindness opacity ,optic neuritis, blindness

• pulmonary fibrosispulmonary fibrosis

Page 44: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

ContinueContinue

• hypo or hyperthyroidismhypo or hyperthyroidism• Nausea & constipationNausea & constipation• Hepatic impairmentHepatic impairment• neurological effects neurological effects • A-V block & bradycardiaA-V block & bradycardia• HypotensionHypotension

Page 45: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Drug interactionsDrug interactions

• Oral anticoagulant Oral anticoagulant bleedingbleeding• DigoxinDigoxindigoxin toxicitydigoxin toxicity• β- blockers β- blockers additive effectadditive effect

Page 46: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Class 1VClass 1V

• Calcium channel blockersCalcium channel blockers• e.g. Verapamil, Diltiazeme.g. Verapamil, Diltiazem• Their main site of action is A.V.N & Their main site of action is A.V.N &

S.A.N.S.A.N.• Effective only in atrial arrhythmias Effective only in atrial arrhythmias

Page 47: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.
Page 48: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

ContinueContinue

• Second drugs of choice for the Second drugs of choice for the treatment of paroxysmal treatment of paroxysmal supraventricular tachycardia supraventricular tachycardia

• Not effective in Wolff Parkinson Not effective in Wolff Parkinson White syndrome.White syndrome.

Page 49: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Adverse effectsAdverse effects

• -Ve inotropic effect causes H.F.-Ve inotropic effect causes H.F.• A-V blockA-V block

• Constipation , headache , Constipation , headache , peripheral edemaperipheral edema

Page 50: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Miscellenous drugsMiscellenous drugs

• AdenosineAdenosineBinds to specific G protein Binds to specific G protein ––

coupled adenosine receptors coupled adenosine receptors

(A(A11&A&A22))opening K+ opening K+ channelchannelhyperpolarization.hyperpolarization.

• influx of calciuminflux of calcium

Page 51: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Pharmacokinetics & UsesPharmacokinetics & Uses

• Very rapid onset of action .Very rapid onset of action .• Short half- life (seconds)Short half- life (seconds)• Given as a Given as a rapidrapid I.V. bolus injection I.V. bolus injection

For the acute termination of For the acute termination of re-entrant supraventricular re-entrant supraventricular tachycardia ( paroxysmal tachycardia ( paroxysmal attack) attack) First choice.First choice.

Page 52: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Adverse effectsAdverse effects

• BronchospasmBronchospasm• Chest painChest pain• Shortness of breathShortness of breath• FlushingFlushing• A-V blockA-V block• HypotensionHypotension

Page 53: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

ContraindicationsContraindications

• Bronchial asthmaBronchial asthma• A-V blockA-V block

Page 54: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

Drug interactionsDrug interactions

• Less effective with adenosine Less effective with adenosine receptor blockers ( Caffeine or receptor blockers ( Caffeine or theophylline theophylline

• More effective with uptake More effective with uptake inhibitors as dipyridamole inhibitors as dipyridamole

Page 55: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

MagnesiumMagnesium

• Used in:Used in:• Digitalis induced arrhythmiasDigitalis induced arrhythmias• Torsade de pointesTorsade de pointes• Sinus tachycardiaSinus tachycardia

Page 56: Antiarrhythmic Drugs Normal heart rateNormal heart rate Action potentialAction potential ECGECG.

PotassiumPotassium

• Used in:Used in:• Digitalis induced arrhythmiasDigitalis induced arrhythmias